GLP-1 medicines, which mimic a hormone important to appetite, satiety and digestion, are effective in leading to weight loss
The risk is much higher in terms of potential harm. After the FDA alerted Empower about problems with its ingredients in 2022, the company acknowledged the findings and said it would place those questionable materials on a hold pending an investigation, records show
It might also be prescribed if you have a BMI of 27 and at least one weight-related health condition, including high blood pressure, high cholesterol, or cardiovascular disease
What should I do before starting Semaglutide
Thomson et al., 2014)
However, if dietary iron intake declines significantly, particularly in menstruating women, iron stores may gradually decrease